|
|
|
Baldwin's Supreme Court nominee fight is early flashpoint
Local Legal Events |
2017/04/07 03:23
|
Wisconsin Democratic Sen. Tammy Baldwin's support for a filibuster to block President Donald Trump's pick for the U.S. Supreme Court has become an early flashpoint as she faces re-election next year.
While Baldwin and Republicans, including her Wisconsin colleague Sen. Ron Johnson, trade barbs over the nomination of Neil Gorsuch, voters back home in a state that went for Trump in November worry about the continued erosion of bipartisanship and increasing polarization in Washington.
"Nobody is making any concessions and I think this is going to be the downfall of both parties," said Anna Street, a 56-year-old nurse from West Allis, on Tuesday.
Baldwin voted Thursday to support a Democratic filibuster in an attempt to stop Gorsuch's nomination to the nation's highest court, while Johnson voted to end debate. Baldwin argues that Trump should put forward someone who could get enough bipartisan support to garner 60 votes and overcome any filibuster.
But Republicans, on a party-line vote with Johnson in support and Baldwin opposed, changed Senate rules on Thursday to eliminate the filibuster for Supreme Court nominees, a move labeled the "nuclear option" because it would unravel Senate traditions that have led to reaching bipartisan consensus.
"Republicans and Democrats ought to get to a point where they're talking to each other and not go on with this," said Roger Sunby, a retired public education administrator from Mount Horeb. He said Gorsuch would be confirmed no matter what action Democrats take.
Republicans see Baldwin's opposition to Gorsuch as a vulnerability. Johnson, Gov. Scott Walker and other Republicans have been attacking Baldwin as being out of the "mainstream" because of her opposition to Gorsuch.
Baldwin argues that it's not her, but Gorsuch, who is out of the mainstream, citing his rulings "against disabled students, against workers, and against women's reproductive health care."
Baldwin said in a statement after her votes Thursday that she has "deep concerns" about Gorsuch's record and that she wants a justice who will serve as a check on the executive branch.
"Based on his record and the many questions he has chosen to leave unanswered, I don't have confidence Judge Gorsuch would be that justice and I oppose his confirmation to our highest court," she said.
Baldwin backers argue that her support for a filibuster will only further bolster her bona fides among liberals as someone willing to stand up to Trump.
|
|
|
|
|
|
|
Donnelly facing doubts from Indiana liberals over court vote
Legal World News |
2017/04/06 23:23
|
A small protest by liberals outside Democratic Sen. Joe Donnelly's downtown Indianapolis office this week could signal trouble for his 2018 re-election hopes.
Some of those who protested against Donnelly's decision to break with his party and to support Judge Neil Gorsuch's nomination to the Supreme Court said they were uneasy about voting for him next year. That liberal pushback against the moderate Donnelly comes as he's already being targeted by national Republicans in a state that President Donald Trump carried by 19 percentage points.
Pamela Griffin, a retired Indianapolis elementary school teacher, said she was going to think "long and hard" about supporting Donnelly in next year's election, while acknowledging it was "kind of a fluke" he was elected in the Republican-dominated state in 2012.
"He's rubber-stamped some stuff that he shouldn't have for Trump," Griffin said. "I'm disappointed in him that he's not really doing what his party would want him to do."
Donnelly won his first Senate term in 2012 with just over 50 percent of the vote and is now the sole Indiana Democrat holding statewide office.
The National Rifle Association ran campaign-style ads in the past week questioning Donnelly's pro-gun stance if he wasn't willing to support Gorsuch, which he did on Thursday, joining three other Democrats who voted to end his party's filibuster. Two Republican U.S. House members, Reps. Luke Messer and Todd Rokita, have signaled they may challenge Donnelly for his seat next year.
Donnelly has tried to cultivate an independent image, highlighting his work on veterans issues and trying to stop the loss of Indiana factory jobs. He has supported some of Trump's Cabinet picks but he's also spoken out against the failed Republican health care bill.
Donnelly said Sunday that he would vote to confirm Gorsuch, whom he described as qualified and well respected. He and two of the other Democratic senators who support Gorsuch — Joe Manchin of West Virginia, Heidi Heitkamp of North Dakota — are moderates from states that Trump won by big margins last November. The fourth, Sen. Michael Bennet from Gorsuch's home state of Colorado, said he wouldn't join the filibuster but hasn't said how he would vote on Gorsuch's confirmation.
|
|
|
|
|
|
|
New Ohio lethal injection process rejected by appeals court
Legal Information |
2017/04/04 23:24
|
A federal appeals court on Thursday rejected Ohio's new three-drug lethal injection process, jeopardizing the upcoming executions of several condemned killers.
In a 2-1 decision, the 6th U.S. Circuit Court of Appeals in Cincinnati found the proposed use of a contested sedative, midazolam, unconstitutional. The court also ruled that Ohio's planned use of two other drugs the state abandoned years ago prevents their reintroduction in a new execution system.
After repeatedly saying it would no longer use those drugs — pancuronium bromide and potassium chloride — "but now attempting to execute condemned inmates with these very drugs, the State had taken directly contradictory positions," Judge Karen Nelson Moore ruled for the majority.
The court also favored arguments by attorneys for death row inmates that use of another drug altogether — pentobarbital — is still an option, despite Ohio's arguments that it can't find supplies of that drug.
An appeal is likely. Options including asking the full appeals court to consider the case or appealing straight to the U.S. Supreme Court, said Dan Tierney, a spokesman for the Ohio attorney general's office.
The ruling was a blow to the state, which hoped to begin executing several condemned killers next month. The first of those, Ronald Phillips, is scheduled to die May 10 for raping and killing his girlfriend's 3-year-old daughter in Akron in 1993.
Allen Bohnert, a lawyer for death row inmates challenging Ohio's lethal injection system, applauded the decision, saying the appeals court was correct in rejecting the execution process.
Executions have been on hold since January 2014, when inmate Dennis McGuire took 26 minutes to die under a never-before-tried two-drug method that began with midazolam. The same drug was involved in a problematic execution later that year in Arizona.
Ohio announced its three-drug method in October and said it had enough for at least four executions, though records obtained by The Associated Press indicated the supply could cover dozens of executions.
The drugs are midazolam, rocuronium bromide — like pancuronium bromide, a drug used to paralyze inmates — and potassium chloride.
The prison system used 10 milligrams of midazolam on McGuire. The new system calls for 500 milligrams. The state said there's plenty of evidence proving the larger amount will keep inmates from feeling pain.
Ohio also said the U.S. Supreme Court upheld the use of midazolam in 2015 in a case out of Oklahoma.
The court on Thursday said arguments by death row inmates that even 500 milligrams of midazolam could lead to a risk of pain were more convincing than counterarguments from the state.
|
|
|
|
|
|
|
Arkansas asks court to block order on execution drugs
Court Updates |
2017/04/02 16:06
|
Arkansas prison officials asked the state's highest court Friday to stay a judge's order that they must disclose more information about one of the drugs they plan to use in the executions of eight men over a 10-day period in April.
The attorney general's office asked the state Supreme Court to issue a stay of Pulaski County Circuit Judge Wendell Griffen's order requiring Arkansas to release copies of the package insert and labels for its supply of potassium chloride, one of the three drugs used in its lethal injection protocol.
The state said it had released the documents, but had redacted information on the labels that it says could lead to identification of the drug's supplier. Steven Shults, the attorney who sued the state for the information, declined to comment on the case Friday.
Shults' attorneys asked the court to deny the state's motion, saying there was no evidence that the information withheld would identify the drug's supplier.
The filing said releasing all of the information would give Shults "an unreviewable victory that will completely undermine and obviate the confidentiality provisions" of the state's lethal injection law.
Arkansas hasn't executed an inmate since 2005 because of legal challenges and difficulty obtaining drugs. The state's 2015 lethal injection law keeps secret the source of the state's execution drugs.
The prison officials, who plan to execute eight inmates in a 10-day period next month before another one of the state's lethal drugs expires April 30, had refused to release packing slips that detail how the drugs are to be used. The Associated Press has previously used the labels to identify drugmakers whose products would be used in executions against their will. The AP renewed its request after the state acquired its potassium chloride in March, but was also rejected.
|
|
|
|
|
|
Law Firm News RSS Feed
